NCT04701983 Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT04684524 Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) Status COMPLETED Phase PHASE3
NCT04681729 Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS) Status COMPLETED Phase PHASE3
NCT04679480 Anti-PD1-antibody and Pulsed HHI for Advanced BCC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04678661 My Dose Coach Mobile App to Support Insulin Titration and Maintenance Status TERMINATED Phase NA
NCT04669041 A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy Status COMPLETED Phase PHASE3
NCT04661527 Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19 Status UNKNOWN Phase PHASE2
NCT04661033 Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA) Status TERMINATED Phase PHASE2
NCT04659603 Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors Status TERMINATED Phase PHASE2
NCT04656600 Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ Status COMPLETED Phase PHASE4
NCT04653246 Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04643002 Isatuximab in Combination With Novel Agents in RRMM - Master Protocol Status RECRUITING Phase PHASE1/PHASE2
NCT04618237 Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient Status UNKNOWN Phase N/A
NCT04583618 Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years. Status COMPLETED Phase PHASE2
NCT04572841 Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) Status COMPLETED Phase PHASE2
NCT04558931 Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma Status RECRUITING Phase PHASE2